School of Traditional Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, China.
Department of Pathology, School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, China.
Biochem Pharmacol. 2024 Dec;230(Pt 1):116576. doi: 10.1016/j.bcp.2024.116576. Epub 2024 Oct 16.
N6-methyladenosine (m6A) is a prevalent mRNA modification in eukaryotic cells, characterized by its reversible nature. YTH structural domain family protein 2 (YTHDF2), a key reader of m6A, plays a crucial role in identifying and binding m6A-containing RNAs, thereby influencing RNA metabolism through various functional mechanisms. The upstream and downstream targets of YTHDF2 are critical in the pathogenesis of various central nervous system (CNS) diseases, affecting disease development by regulating signaling pathways and gene expression. This paper provides an overview of current research on the role of YTHDF2 in CNS diseases and investigates the regulatory mechanisms by which YTHDF2 influences the development of these conditions. This exploration aims to improve understanding of disease pathogenesis and offer novel insights for the targeted prevention and treatment of neurological disorders.
N6-甲基腺苷(m6A)是真核细胞中一种普遍存在的 mRNA 修饰,其特点是具有可逆性。YTH 结构域家族蛋白 2(YTHDF2)是 m6A 的主要阅读器,在识别和结合含有 m6A 的 RNA 方面发挥着关键作用,从而通过各种功能机制影响 RNA 代谢。YTHDF2 的上下游靶点在各种中枢神经系统(CNS)疾病的发病机制中至关重要,通过调节信号通路和基因表达来影响疾病的发展。本文综述了 YTHDF2 在 CNS 疾病中的作用的研究现状,并探讨了 YTHDF2 影响这些疾病发展的调控机制。这种探索旨在提高对疾病发病机制的认识,并为神经障碍的靶向预防和治疗提供新的见解。